Motesanib diphosphate can induce partial remissions in patients with progressive advanced metastatic differentiated thyroid cancer unresponsive to surgery, external beam radiotherapy and 131 I
Year: 2009
Type: article
Study design: Clinical Trial
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W238143822
